1[1]Moller S, Hansen EF, Becker U,et al. Central and systemic haemodynamiceffects of terliprcssin in portal hypertensive patients [J ]. Liver. 2000,20:51~ 59
2[2]Chatila R, Ferayomi L, Gupta T, et al. Local arterial vasoconstriction in duced by octreotide in patients with cirrhosis[J]. Hepatology. 2000, 31:572 ~ 576
3[3]Groszman RJ. Hyperdynamic state in chronic liver diseases[J] . J Hepatol ogy. 1993; 17(supplz) :28 ~ 40
4[4]Henriksen JH, Moller S, Schifter S, et al. Increased arterial compliance in decompensated cirrhosis[J]. J Hepatol. 1999,31:712 ~ 718
5[5]Gatta A, Sacerdoti D, Bologncsi M, et al. Portal hypertension: state of the art[J]. Ital J Gastroenterol Hepatol. 1999,31:326~ 345
6[6]Huonker M, Schumacher YO, Ochs A, et al. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt[J]. Gut. 1999,44:743 ~ 748